000 01379 a2200361 4500
005 20250516105334.0
264 0 _c20120904
008 201209s 0 0 eng d
022 _a0317-1671
024 7 _a10.1017/s0317167100018187
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiller, Robert J H
245 0 0 _aChemotherapy-associated steatohepatitis with temozolomide and dexamethasone.
_h[electronic resource]
260 _bThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
_cJul 2012
300 _a547-9 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aDacarbazine
_xadverse effects
650 0 4 _aDexamethasone
_xadverse effects
650 0 4 _aDiabetes Mellitus, Type 2
_xcomplications
650 0 4 _aFatty Liver
_xchemically induced
650 0 4 _aGlioblastoma
_xcomplications
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTemozolomide
650 0 4 _aTime Factors
700 1 _aGui, Xianyong
700 1 _aEasaw, Jacob C
700 1 _aTsang, Roger Y
773 0 _tThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
_gvol. 39
_gno. 4
_gp. 547-9
856 4 0 _uhttps://doi.org/10.1017/s0317167100018187
_zAvailable from publisher's website
999 _c22028568
_d22028568